BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Toshihiko HIDAKA. The mechanism of the efficiency of Leukocytapheresis on Rheumatoid ArthritisJapanese Journal of Clinical Immunology 2011; 34(6): 447 doi: 10.2177/jsci.34.447
2
Ken Fukunaga, Takayuki Matsumoto. Current status and future perspectives of leukocytapheresis for inflammatory bowel diseaseJournal of Gastroenterology and Hepatology 2012; 27(6): 997 doi: 10.1111/j.1440-1746.2012.07119.x
3
Maria T. Abreu, Scott Plevy, Bruce E. Sands, Robert Weinstein. Selective Leukocyte Apheresis for the Treatment of Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology 2007; 41(10): 874 doi: 10.1097/MCG.0b013e3180479435
4
Tamotsu Ishizuka, Takeshi Hisada, Motoaki Hatori, Akio Koike, Kikuo Hanabuchi, Shinichi Matsuzaki, Yosuke Kamide, Mitsuyoshi Utsugi, Haruka Aoki, Reiko Yoshino, Noriko Yanagitani, Yasuhiko Koga, Akihiro Ono, Kyoichi Kaira, Noriaki Sunaga, Kunio Dobashi, Takahiro Tsuburai, Kazuo Akiyama, Masanobu Yamada, Kazuhiro Suzuki, Masatomo Mori. Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthmaInflammation Research 2014; 63(9): 789 doi: 10.1007/s00011-014-0753-1
5
Steven J Brown, Thomas Ullman, David B Sachar. Filtering out the Phagocytes in Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology 2005; 39(10): 845 doi: 10.1097/01.mcg.0000180807.58737.e7
6
Hiroyuki Okada, Ryuta Takenaka, Sakiko Hiraoka, Chiho Makidono, Shin-ichiro Hori, Jun Kato, Hiroaki Okazaki, Hirofumi Kawamoto, Motowo Mizuno, Yasushi Shiratori. Centrifugal Leukocytapheresis Therapy for Ulcerative Colitis Without Concurrent Corticosteroid AdministrationTherapeutic Apheresis and Dialysis 2006; 10(3): 242 doi: 10.1111/j.1744-9987.2006.00379.x
7
Sonomi Kobayashi, Hidehirou Tabata, Akitoshi Andou, Hideki Nishimura, Tsutomu Sanaka, Kosaku Nitta, Takashi Naito. Treatment with leukocytapheresis for refractory intestinal bleeding due to Henoch-Sch^|^ouml;nlein purpura (HSP)Nihon Toseki Igakkai Zasshi 2013; 46(7): 671 doi: 10.4009/jsdt.46.671
8
Hiroshi Yamasaki, Keiichi Mitsuyama, Junya Masuda, Nobuo Tomiyasu, Hiroko Takedatsu, Hirotada Akashi, Satoshi Matsumoto, Hidetoshi Takedatsu, Kotaro Kuwaki, Osamu Tsuruta, Michio Sata. Mechanisms Underlying the Effects of Leukocyte Apheresis with a Fiber Filter in a Rat Model of Dextran Sulfate Sodium-Induced ColitisDigestive Diseases and Sciences 2010; 55(3): 596 doi: 10.1007/s10620-009-0768-6
9
Kunihiko Umekita, Toshihiko Hidaka, Shiro Ueno, Ichiro Takajo, Yasufumi Kai, Yasuhiro Nagatomo, Akira Sawaguchi, Tatsuo Suganuma, Akihiko Okayama. Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: a possible connection with the effect of LCAP on rheumatoid arthritisModern Rheumatology 2009; 19(3): 265 doi: 10.3109/s10165-009-0164-2
10
Kunihiko Umekita, Toshihiko Hidaka, Shiro Ueno, Ichiro Takajo, Yasufumi Kai, Yasuhiro Nagatomo, Akira Sawaguchi, Tatsuo Suganuma, Akihiko Okayama. Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: a possible connection with the effect of LCAP on rheumatoid arthritisModern Rheumatology 2009; 19(3): 265 doi: 10.3109/s10165-009-0164-2
11
Midori Hasegawa, Atsushi Ohashi, Nao Kabutan, Saori Hiramatsu, Masao Kato, Kazutaka Murakami, Makoto Tomita, Kunihiro Nabeshima, Yoshiyuki Hiki, Satoshi Sugiyama. Cytapheresis for the Treatment of Myeloperoxidase Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: A Pilot Study of 21 PatientsTherapeutic Apheresis and Dialysis 2006; 10(5): 412 doi: 10.1111/j.1744-9987.2006.00404.x
12
Ken Fukunaga, Yoshihiro Fukuda, Yoko Yokoyama, Kunio Ohnishi, Takeshi Kusaka, Tadashi Kosaka, Nobuyuki Hida, Yoshio Ohda, Hiroto Miwa, Takayuki Matsumoto. Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patientsJournal of Gastroenterology 2006; 41(6): 524 doi: 10.1007/s00535-006-1789-y
13
Vladislaw Muratov, Joachim Lundahl, Aleksandra Mandic-Havelka, Kerstin Elvin, Åke Öst, Yasumasa Shizume, Kaoru Furuya, Robert Löfberg. Safety and tolerability of a modified filter-type device for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot studyJournal of Clinical Apheresis 2010; 25(5): 287 doi: 10.1002/jca.20255
14
Keiichi Mitsuyama, Michio Sata. Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of actionCytotherapy 2009; 11(2): 229 doi: 10.1080/14653240902725566
15
Takayuki Matsumoto, Akira Andoh, Kiyotaka Okawa, Hiroaki Ito, Ayao Torii, Syusaku Yoshikawa, Ryosuke Nakaoka, Yusuke Okuyama, Nobuhide Oshitani, Masakazu Nishishita, Kenji Watanabe, Ken Fukunaga, Kunio Ohnishi, Takeshi Kusaka, Yoko Yokoyama, Masaya Sasaki, Tomoyuki Tsujikawa, Tetsuya Aoki, Toshihiro Kusaka, Yasuhiro Takeda, Yasushi Umehara, Shiro Nakamura, Yoshihide Fujiyama. Multivariate Analysis for Factors Predicting Rapid Response of Leukocytapheresis in Patients With Steroid-resistant Ulcerative Colitis: A Multicenter Prospective Open-label StudyTherapeutic Apheresis and Dialysis 2008; 12(6): 484 doi: 10.1111/j.1744-9987.2008.00639.x
16
Toshiyuki Matsui. Leukocyte removal therapy before surgery in ulcerative colitisJournal of Gastroenterology 2006; 41(9): 923 doi: 10.1007/s00535-006-1898-7
17
H. Okada, C. Makidono, R. Takenaka, S. Hiraoka, A. Fujiwara, J. Kato, Y. Kawahara, H. Kawamoto, M. Mizuno, Y. Shiratori. Therapeutic Efficacy of Leukocytapheresis in a Pregnant Woman with Severe Active Ulcerative ColitisDigestion 2006; 74(1): 15 doi: 10.1159/000095478
18
Yasumi Araki, Keiichi Mitsuyama, Takaaki Nagae, Yuji Tou, Motonori Nakagawa, Yasue Iwatani, Masakazu Harada, Hiroyuki Ozasa, Michio Sata, Toshihiro Noake. Leukocytapheresis for the treatment of active pouchitis: a pilot studyJournal of Gastroenterology 2008; 43(7): 571 doi: 10.1007/s00535-008-2199-0
19
Takeshi Tomomasa, Hitoshi Tajiri, Seiichi Kagimoto, Toshiaki Shimizu, Atsushi Yoden, Kosuke Ushijima, Keiichi Uchida, Hiroaki Kaneko, Daiki Abukawa, Mutsuko Konno, Shun-ichi Maisawa, Takao Kohsaka, Akio Kobayashi. Leukocytapheresis in Pediatric Patients With Ulcerative ColitisJournal of Pediatric Gastroenterology and Nutrition 2011; 53(1): 34 doi: 10.1097/MPG.0b013e31821058bc
20
Hiroyuki Hanai, Takayuki Iida, Kentaro Ikeya, Jinrou Abe, Yasuhiko Maruyama, Teruyuki Shimura, Ken Sugimoto, Fumitoshi Watanabe. A new paradigm in ulcerative colitis: Regulatory T cells are key factor which induces/exacerbates UC through an immune imbalanceMolecular Immunology 2013; 54(2): 173 doi: 10.1016/j.molimm.2012.11.015
21
Osamu Hotta, Aki Ishida, Tomoyoshi Kimura, Yoshio Taguma. Improvements in Treatment Strategies for Patients With Antineutrophil Cytoplasmic Antibody-associated Rapidly Progressive GlomerulonephritisTherapeutic Apheresis and Dialysis 2006; 10(5): 390 doi: 10.1111/j.1744-9987.2006.00401.x
22
Takayuki Matsumoto, Ken Fukunaga, Koji Kamikozuru, Katsutoshi Tozawa, Yoko Yokoyama, Takeshi Kusaka, Kunio Onishi, Hiroto Miwa, Shiro Nakamura. Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel DiseaseTransfusion Medicine and Hemotherapy 2008; 35(1): 18 doi: 10.1159/000111763